Please assess the completion status of the following clinical trial:

Trial Title: Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Resectable lung nodule or mass~Exclusion Criteria:~* Allergy to amiodarone~* Currently taking amiodarone~* Documented atrial fibrillation within past 12 months~* Known pulmonary fibrosis~* Known hepatic dysfunction~* Thyroid disease~* 2nd or 3rd degree heart block~* Severe SA node disease~* Bradycardia-induced syncope~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 - Amiodarone (Type: EXPERIMENTAL): Perioperative amiodarone
- 2 - Control (Type: ACTIVE_COMPARATOR): Control arm, standard care with no perioperative amiodarone

Based on this trial design, predict the completion outcome and termination type (if applicable).